{"id":13560,"date":"2008-04-18T00:00:00","date_gmt":"2008-04-17T21:00:00","guid":{"rendered":"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/"},"modified":"2008-04-18T00:00:00","modified_gmt":"2008-04-17T21:00:00","slug":"regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review","status":"publish","type":"post","link":"https:\/\/www.invaldainvl.com\/en\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/","title":{"rendered":"Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review"},"content":{"rendered":"\n<p>Invalda AB accepts an offer to review its subsidiary&#8217;s Sanitas AB strategic options to explore ways to enhance shareholders value. <\/p>\n<p>Invalda AB takes into account that the review of strategic options may, or may not, lead to any proposal being made to shareholders of Sanitas AB and Sanitas AB continues to remain focused on the execution of its operating plan. <\/p>\n<p>After estimation of possible alternatives, the Board of Invalda AB will be ready to consider them and make decisions. <br \/>&nbsp;<\/p>\n<p>Darius Sulnis<br \/>President<br \/>+370 5 273 48 76<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Invalda AB accepts an offer to review its subsidiary&#8217;s Sanitas AB strategic options to explore ways to enhance shareholders value. Invalda AB takes into account that the review of strategic..<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[6],"class_list":["post-13560","post","type-post","status-publish","format-standard","hentry","category-regulated-information","tag-imported"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review - Invalda INVL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review - Invalda INVL\" \/>\n<meta property=\"og:description\" content=\"Invalda AB accepts an offer to review its subsidiary&#8217;s Sanitas AB strategic options to explore ways to enhance shareholders value. Invalda AB takes into account that the review of strategic..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/\" \/>\n<meta property=\"og:site_name\" content=\"Invalda INVL\" \/>\n<meta property=\"article:published_time\" content=\"2008-04-17T21:00:00+00:00\" \/>\n<meta name=\"author\" content=\"wkd\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"wkd\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/\"},\"author\":{\"name\":\"wkd\",\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424\"},\"headline\":\"Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review\",\"datePublished\":\"2008-04-17T21:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/\"},\"wordCount\":92,\"commentCount\":0,\"keywords\":[\"Imported\"],\"articleSection\":[\"Regulated information\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/\",\"url\":\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/\",\"name\":\"Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review - Invalda INVL\",\"isPartOf\":{\"@id\":\"https:\/\/www.invaldainvl.com\/#website\"},\"datePublished\":\"2008-04-17T21:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.invaldainvl.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.invaldainvl.com\/#website\",\"url\":\"https:\/\/www.invaldainvl.com\/\",\"name\":\"Invalda INVL\",\"description\":\"Invalda INVL\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.invaldainvl.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424\",\"name\":\"wkd\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.invaldainvl.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6edb7b2b6ec752de6b92ee190810a20be9cc6219f961b7fe5053c63dcf92c4a8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6edb7b2b6ec752de6b92ee190810a20be9cc6219f961b7fe5053c63dcf92c4a8?s=96&d=mm&r=g\",\"caption\":\"wkd\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review - Invalda INVL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/","og_locale":"en_US","og_type":"article","og_title":"Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review - Invalda INVL","og_description":"Invalda AB accepts an offer to review its subsidiary&#8217;s Sanitas AB strategic options to explore ways to enhance shareholders value. Invalda AB takes into account that the review of strategic..","og_url":"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/","og_site_name":"Invalda INVL","article_published_time":"2008-04-17T21:00:00+00:00","author":"wkd","twitter_card":"summary_large_image","twitter_misc":{"Written by":"wkd"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/#article","isPartOf":{"@id":"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/"},"author":{"name":"wkd","@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424"},"headline":"Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review","datePublished":"2008-04-17T21:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/"},"wordCount":92,"commentCount":0,"keywords":["Imported"],"articleSection":["Regulated information"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/","url":"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/","name":"Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review - Invalda INVL","isPartOf":{"@id":"https:\/\/www.invaldainvl.com\/#website"},"datePublished":"2008-04-17T21:00:00+00:00","author":{"@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424"},"breadcrumb":{"@id":"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.invaldainvl.com\/regulated-information\/regarding-approval-of-subsidiarys-sanitas-ab-strategic-options-review\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.invaldainvl.com\/en\/"},{"@type":"ListItem","position":2,"name":"Regarding approval of subsidiary&#039;s Sanitas AB strategic options&#039; review"}]},{"@type":"WebSite","@id":"https:\/\/www.invaldainvl.com\/#website","url":"https:\/\/www.invaldainvl.com\/","name":"Invalda INVL","description":"Invalda INVL","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.invaldainvl.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/46ab7fa082fd2b7cc7794f370fb41424","name":"wkd","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.invaldainvl.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6edb7b2b6ec752de6b92ee190810a20be9cc6219f961b7fe5053c63dcf92c4a8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6edb7b2b6ec752de6b92ee190810a20be9cc6219f961b7fe5053c63dcf92c4a8?s=96&d=mm&r=g","caption":"wkd"}}]}},"_links":{"self":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/posts\/13560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/comments?post=13560"}],"version-history":[{"count":0,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/posts\/13560\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/media?parent=13560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/categories?post=13560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.invaldainvl.com\/en\/wp-json\/wp\/v2\/tags?post=13560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}